Search
Close this search box.

Regulatory Compliance for Medical Devices in India: A Step-by-Step Guide

Estimated reading time : 

10 Minutes

India is one of the world’s largest producers of medical and in-vitro medical devices, with thousands of devices manufactured every year. The manufacturing and sale of these devices are governed by the Central Drugs Standard Control Organization (CDSCO), which regulates their safety, efficacy, and quality.

 

The CDSCO’s main objective is to maintain a balance between the benefits and risks of medical devices, ensuring that they meet the highest safety and quality standards. To achieve this, the CDSCO has established a comprehensive regulatory framework that includes licensing, inspection, and post-market surveillance.

In 2022, the Indian government announced the National Medical Devices Policy, which aims to reduce the country’s dependence on imports and promote domestic manufacturing. Under this policy, the government will provide incentives and support to medical device manufacturers, such as expedited licensing and regulatory approvals, tax incentives, and funding for research and development.

 

The policy is expected to stimulate growth in the medical device industry and create new opportunities for both local and foreign manufacturers. As the Indian medical device market continues to expand, it is essential for companies to stay abreast of the latest regulations and requirements to ensure compliance and maintain a competitive edge.

Definition of Medical Device and In- vitro as per Medical Device Rule,2017.

DEFINITION
Medical Devices

1. All those substances used for in-vitro diagnosis or surgical purposes, such as dressings, bandages, sutures, ligatures, blood, and its component collection bags with or without coagulant under sub-clause (i).

2. Substances such as mechanical contraceptives (condoms, intrauterine devices, tubal rings), disinfectants, and insecticides, notified in the Official Gazette under sub-clause (ii),

3.Devices are notified from time to time under sub-clause (iv) of clause (b) of section 3 of the Act.

In-Vitro Medical Devices

As per sub-clause (A) of clause (ZB), medical devices used in vitro diagnosis not approved by the CLA for importation and are tested to establish their performance for relevant analysis or other parameters related to it, including details of technology and the procedure required;

The Medical Devices/ In-Vitro Diagnostic devices are classified as follows:

Class

Medical Device

In-Vitro Diagnostic

A – Low risk

B – Low Moderate Risk

C – Moderate Risk

D – High Risk

To Import Medical Devices/ In Vitro Diagnostics Medical devices in India, the below-listed Application Forms need to file with Licensing Authority.

 Form No.

Description

Devices and Class

Fees

Licensing Authority

MD Form – 14:

Application to import medical devices

Only medical devices and classes A, B, C & D.

For class A: $1000 & $500 per product.

For class B: $2000 & $500 per product.

For class C & D: $3000 & & $1500 per product.

 

 

 

 

 

CDSCO

MD Form -15 (Approval)

Permission to import medical devices.

MD Form – 28

Application to import In-Vitro medical devices

Only In-Vitro medical devices and classes A, B, C & D.

For classes A & B: $1000 & $10 per product.

For class C & D: $3000 & $500 per product.

MD Form – 29:

Permission to import In-Vitro medical devices.

 

CDSCO – The Central Drugs Standard Control Organization (CDSCO) is responsible for regulating the manufacturing and sale of medical devices in India. Under the control of the Drug Controller General of India (DCGI), the CDSCO follows the Drug and Cosmetic Act of 1940 and rules of 1945.

The CDSCO classifies medical devices into two categories: Notified Devices and Non-notified devices. Notified Devices, numbering 37 in total, require prior permission from the CDSCO before they can be sold in the Indian market. Non-notified devices must be present on the CDSCO portal, and foreign manufacturers who want to sell devices must have an Indian Authorized Agent (IAA).


In addition to CDSCO regulations, the Legal Metrology Packaged Commodity Act of 2009 and rules of 2011 is a mandatory license for the manufacture of medical and in-vitro medical devices in India. The main objective of legal metrology is to ensure firms follow measurement and packaging rules established by the department.

Furthermore, the Plastic Waste Management Rule of 2016 aims to reduce plastic usage and waste. Obtaining a PWM license is essential when setting up a medical and in-vitro medical device manufacturing site to avoid delays in the manufacturing process. Compliance with these regulations is critical for manufacturers to ensure safety, quality, and environmental sustainability.

CDSCO

LPMC

PWM

Medical devices (class A, B, C & D)

In-Vitro Medical devices (class A, B, C & D)

For medical and In-Vitro medical devices (class A, B.C & D)

For medical and In-Vitro medical devices (class A, B.C & D)

Applicants Details

Cover letter

Manufacturers’ names and addresses.

Copy of valid Consent to Operate.

Information of product

Documents related to regulatory

Name and address of packer (if packed somewhere else).

Copy of registration certificate issued by the Ministry of Micro, Small, and Medium Enterprises

Status of regulatory

Power of Attorney

Generic name of medical and in-vitro medical devices.

Manufacturing process flowchart & Description.

Clearance from other countries.

ISO 13485 Certificate

Name and number of medical and in-vitro medical devices (if packed more than one).

Specifications of Pollution Control devices.

Master file

Fees Challan

Net weight

Images of the unit/production site.

The device has a medicinal product.

Certificates of GMP, CE design, free sale, and batch release certificates.

Month and year of manufacturing.

Specification and related documents of plastic being ordered or supplied with details like the name of the industry, plastic packing type, quantity, etc.

Post-market surveillance information

Conformity Declaration

MRP

A copy of the integrated manufacturer’s responsibility approved by the Urban development department

Report of PMS

Name and address to file a complaint.

An EPR compliance report in case of registration renewal.

Business License / Plant Registration Certificate and Quality certificate by overseas Manufacturer assurance of product’s quality.

Documents of proof of medical and in-vitro medical devices business.




Medical devices (class A, B, C & D)

In-Vitro Medical devices (class A, B, C & D)

For medical and In-Vitro medical devices (class A, B.C & D)

For medical and In-Vitro medical devices (class A, B.C & D)

Audit Report and test report with details.

Proof of medical and in-vitro medical devices manufacturing site.

Constitutional Details of partners.

Detail of material used in packaging the medical and in-vitro medical devices.

The authorized agent must have a valid wholesale or manufacturer license.

Label pasted on the medical and in-vitro medical devices.

Plan master files

List of all medical and in-vitro medical devices being manufactured.

Director nomination:

Annexure I:

The company must inform the concerned controller or their authorized officer by giving a duplicate notice (format present in schedule no. thirteen).

As per Annexure I, there are three alternative paths to implement the EPR Plan for the PWM in the states/UT they are planning to set up their manufacturing site.

It consists of the name and address of the director with its writing consent, whom the company has nominated as per section 49 sub-section (2).

a) With their distribution channel.

The director would be responsible for running the company or manufacturing unit.

b) With the direct participation of the municipality.




Medical devices (class A, B, C & D)

In-Vitro Medical devices (class A, B, C & D)

For medical and In-Vitro medical devices (class A, B.C & D)

For medical and In-Vitro medical devices (class A, B.C & D)

c) With the waste management agency (WMA).

Steps to get a manufacturing license for medical and in-vitro medical devices:

Conclusion: Most individuals believe that obtaining just a CDSCO license is sufficient authorization to establish a production facility for in-vitro and medical products. But they are astonished when they find out that other licenses are necessary for addition to CDSCO.

How NKG can help:

For the past two decades, NKG has been helping more than five thousand clients worldwide, across the healthcare spectrum, to get their products registered. The dedicated regulatory team of NKG has more than ten years of experience in helping clients cross the hurdles they face while marketing their products to sell or distribute in India.

 

Have a query, drop it at contact@nkgabc.com

Picture of Navraj Bindra
Navraj Bindra
Navraj Bindra is a Director - Regulatory Expert & Strategy at NKG. He is behind regulatory approvals of more than 1500 beauty brands in India. He has spent 10 years in NK Group which was founded by his father Mr. GK Bindra in 2005.The name NKG now synonymous with reliability, transparency and efficiency in India & the world. The core team is a family with Founder & Father Mr. GK Bindra & two sons Navraj Bindra & Karan Bindra who work together.

Continue reading

May 17, 2024
BIS Regulation for Textiles in India
May 14, 2024
Post Approval Changes for Cosmetics
Scroll to Top

Download our E-Books for Now

Subscribe to Our

Newsletter

To be updated with all the latest trends and services

You are subscribing to receive regular updates